Trial Profile
Phase I study of SJP-0118 in healthy elderly (once a daily and twice a daily dosing study)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Jul 2016
Price :
$35
*
At a glance
- Drugs Azithromycin (Primary)
- Indications Blepharitis; Infectious conjunctivitis; Ocular inflammation
- Focus Adverse reactions
- Sponsors Senju Pharmaceutical
- 28 Jul 2016 Status changed from not yet recruiting to completed.
- 17 May 2016 New trial record